CMP Development, LLC: Clinical Trials

1 trial sponsored by CMP Development, LLC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Not yet recruiting 1

Follow CMP Development, LLC: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Spironolactone Oral Suspension in Pediatric Patients
Spironolactone Oral Suspension - Edema Due to Heart Failure or Cirrhosis
Phase 4Not yet recruitingCMP Development, LLC962027-06-012026-10-22

Conditions studied

Fibrosis (1)

Interventions

Canrenoic Acid (1)

Top investigators

Gerald Sakowski (1)